Matthew M. Heeney, MD

Clinical Director, Pediatric Blood Disorders Center

Associate Chief, Hematology

Director, Sickle Cell Program

Senior Physician

Associate Professor of Pediatrics, Harvard Medical School
Office Phone: 617-919-3242
Appointment Phone: 617-355-8246, ext. 1
Fax: 617-730-0641
Preferred Contact Method: office phone

General

Treatment Centers
Discipline
Pediatric Hematology/Oncology
Clinical Interests
Hemochromatosis, Hemoglobinopathies, Iron deficiency, Sickle cell disease, Sideroblastic anemia

Location

Boston Children's Hospital
300 Longwood Ave.
Boston, MA  02115

Background

Board Certifications
Pediatric Hematology/Oncology, 2009
Pediatrics, 2010
Fellowships
Duke University Medical Center, 2002
Residency
Montreal Children's Hospital, McGill University, 1999
Medical School
University of Calgary, 1995
Biography
Matthew Heeney, MD, is board certified in pediatrics and pediatric hematology/oncology. He is the Associate Chief for Hematology in the Division of Hematology/Oncology and the Director of the Sickle Cell Program in Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Dr. Heeney's research interests are focused on sickle cell disease and congenital disorders of iron metabolism. The goals of Dr. Heeney's research include improving the understanding of the pathophysiology and treatment of sickle cell anemia through clinical investigation and elucidating the genetic basis of iron homeostasis and its role in human disease.

Dr. Heeney has been the Boston Children's Hospital Site Investigator for several clinical trial consortia including the former Sickle Cell Disease Research Network (SCDCRN) and Comprehensive Sickle Cell Center (CSCC). He is also the Site Investigator for the multicenter SWiTCH and TWiTCH trials, which are exploring the use of Hydroxyurea as an alternative to chronic transfusion for stroke prevention in sickle cell disease. He is also involved in early phase trials of prasugrel and regadenoson in sickle cell disease. Dr. Heeney also conducts translational research in inherited disorders of iron homeostasis in humans. In particular, he is interested in investigating the genetic basis inherited disorders of iron deficiency, sideroblastic anemia, and iron overload.

Dr. Heeney is an Associate Professor of Pediatrics at Harvard Medical School (HMS) and is committed to medical education as the Co-Director of the Hematology course for second year HMS students. He is a frequent lecturer on hematology topics in HMS-sponsored continuing medical education and BCH training programs.

Dr. Heeney received his MD at the University of Calgary, Alberta; completed his pediatrics residency at Montreal Children's Hospital, McGill University; and completed a pediatric hematology/oncology fellowship at Duke University.

Video: Meet Video 1

Appointments & Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Clinical Trials

Search our wide range of clinical trials, including novel therapies, immunotherapy and personalized therapy.callout bg

Harvard Medical Affiliate

HMS Callout FAD 

As a teaching affiliate of Harvard Medical School, our physicians are passing on their expertise to the next generation of pediatric hematologists and oncologists.